Profile data is unavailable for this security.
About the company
AIM Vaccine Co Ltd is a China-based company mainly engaged in vaccine research and development, manufacturing and sales. The Company's commercialized products mainly include recombinant HBV vaccine, freeze dried human rabies vaccine, inactivated HAV vaccine, mumps vaccine, bivalent inactivated HFRS vaccine and Group A, C, Y and W135 MPSV. The Company's vaccine products under development include 13-Valent Pneumonia Conjugate Vaccine, 24-Valent Pneumonia Conjugate Vaccine, quadrivalent influenza virus vaccine, iterative serum-free rabies vaccine, mRNA shingles/herpes zoster vaccine, Iterative mRNA rabies vaccine, mRNA respiratory syncytial virus vaccine, novel-process highly-effective human diploid rabies vaccine, and others.
- Revenue in HKD (TTM)1.43bn
- Net income in HKD-304.78m
- Incorporated2011
- Employees1.49k
- LocationAIM Vaccine Co Ltd25/FBuilding A, 91 Jianguo Road, ChaoyangBEIJING 110000ChinaCHN
- Phone+86 1 085950689
- Fax+86 1 085950063
- Websitehttps://www.aimbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhaoke Ophthalmology Ltd | 40.05m | -315.22m | 1.90bn | 270.00 | -- | 0.9779 | -- | 47.34 | -0.5698 | -0.5698 | 0.0725 | 3.54 | 0.0159 | 1.38 | 9.25 | 136,211.20 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.29bn | 412.00 | 10.46 | 2.12 | 8.23 | 2.81 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.48bn | 139.79m | 2.32bn | 1.63k | 14.82 | 1.30 | 12.42 | 1.57 | 0.6472 | 0.6472 | 7.24 | 7.37 | 0.7509 | 1.55 | 2.17 | 959,578.90 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.66m | 2.32bn | 842.00 | 7.64 | 1.70 | 6.80 | 2.09 | 0.4107 | 0.4107 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,269,576.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.51bn | 1.43k | 8.04 | 1.10 | 6.78 | 1.45 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
| SinoMab Bioscience Ltd | 0.00 | -163.48m | 2.62bn | 61.00 | -- | 8.26 | -- | -- | -0.151 | -0.151 | 0.00 | 0.2288 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| AIM Vaccine Co Ltd | 1.43bn | -304.78m | 3.79bn | 1.49k | -- | 1.01 | -- | 2.65 | -0.2507 | -0.2507 | 1.18 | 3.05 | 0.174 | 0.7724 | 1.12 | 931,534.60 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.88m | 4.55bn | 197.00 | -- | 5.49 | -- | -- | -0.7667 | -0.7667 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 857.13m | 36.28m | 4.82bn | 714.00 | 121.78 | 1.93 | 36.55 | 5.63 | 0.0636 | 0.0636 | 1.51 | 4.01 | 0.2530 | 1.34 | 1.73 | 1,054,275.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 195.14m | 4.92bn | 2.09k | 32.59 | 1.11 | 9.78 | 2.37 | 0.0709 | 0.0709 | 0.6816 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,008,351.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.87bn | 488.95m | 5.62bn | 3.89k | 11.50 | 0.6804 | 4.54 | 0.7145 | 0.3818 | 0.3818 | 6.14 | 6.45 | 0.482 | 0.8615 | 6.00 | 1,971,759.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
Data as of Feb 13 2026. Currency figures normalised to AIM Vaccine Co Ltd's reporting currency: Hong Kong Dollar HKD
4.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Wealth Asset Management Ltd.as of 09 Oct 2024 | 23.53m | 4.64% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 980.40k | 0.19% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 447.40k | 0.09% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 30.50k | 0.01% |
| DFA Australia Ltd.as of 30 Nov 2025 | 827.00 | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Hang Seng Investment Management Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Jupiter Asset Management Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 20 Jan 2026Source: FactSet Research Systems Inc.
